Stay updated on Empagliflozin for Heart Attack Patients Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin for Heart Attack Patients Clinical Trial page.

Latest updates to the Empagliflozin for Heart Attack Patients Clinical Trial page
- Check4 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check11 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check32 days agoChange DetectedThe website has updated the intervention type and posted new results as of January 7, 2025, while removing the previous submission from November 14, 2023.SummaryDifference2%
- Check62 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check69 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
Stay in the know with updates to Empagliflozin for Heart Attack Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin for Heart Attack Patients Clinical Trial page.